Genmab A (GMAB) Times Interest Earned (2019 - 2026)
Genmab A's (GMAB) quarterly Times Interest Earned came in at -$1.2 in Q1 2026, up 71.28% YoY from -$0.7 in Q1 2025, and up 79.74% on a QoQ basis from -$5.92 in Q3 2025.
Genmab A (GMAB) Times Interest Earned (2019 - 2026) Analysis & Trends
Genmab A (GMAB) has 5 years of Times Interest Earned data on file, last reported at -$1.2 in Q1 2026.
- Quarterly Times Interest Earned rose 71.28% year-over-year to -$1.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.34 (down 21.59% YoY) and the FY2025 annual result came in at $3.96, up 18.53% from the prior year.
- Times Interest Earned grew to -$1.2 in Q1 2026, from -$5.92 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $4.4 in Q2 2024 to a low of -$5.92 in Q3 2025.
- A 3-year average of -$1.4 and a median of -$3.31 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2025 — Times Interest Earned tumbled 61.96% — and 2026, when it surged 71.28%.
- Tracing GMAB's Times Interest Earned over 3 years: stood at -$3.66 in 2024, then tumbled by 61.96% to -$5.92 in 2025, then jumped by 79.74% to -$1.2 in 2026.
- The last three Times Interest Earned figures came in at -$1.2 (Q1 2026), -$5.92 (Q3 2025), and $4.09 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn | 2.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 |
| Mar 31, 2026 | -1.20 |
| Sep 30, 2025 | -5.92 |
| Jun 30, 2025 | 4.09 |
| Mar 31, 2025 | -4.18 |
| Sep 30, 2024 | -3.66 |
| Jun 30, 2024 | 4.40 |
| Mar 31, 2024 | -3.31 |
| Sep 30, 2020 | 0.07 |
| Dec 31, 2019 | -86.38 |